Canada Magnetic Resonance Imaging (MRI) Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Canada Magnetic Resonance Imaging (MRI) Market Trends and Insights

Growing Burden of Chronic Diseases

Quantum-hyperpolarized MRI amplifies metabolic signals by 100,000-fold, enabling clinicians to map tumor metabolism without radioactive tracers and detect malignancies that conventional imaging misses ^{[1]Technical University of Munich, “Quantum Technology for Cancer Imaging,” EurekAlert, eurekalert.org}. Uptake is strongest in oncology centers treating pancreatic and brain cancers, where early identification drives survival odds and reimbursement aligns with improved outcomes. Regulatory agencies in the United States and Europe are adapting approval pathways to accommodate these quantum-enhanced sequences. Hospitals that adopt the technology report higher referral capture, reinforcing long-run demand for premium scanners in the MRI systems market.

Aging Population & Rising Imaging Referrals

The median age in advanced economies surpasses 40 years, raising the incidence of stroke, osteoarthritis, and neurodegenerative diseases. Portable systems cleared for bedside neurological use shorten door-to-scan times, particularly for stroke triage in emergency units. Point-of-care imaging also supports geriatric care in long-term facilities that lack room for conventional suites. These access gains translate into higher annual scan volumes, a positive demand loop for the MRI systems market.

Government Funding to Cut MRI Wait-Times

Ontario allocated USD 70 million for helium-free systems, while British Columbia set a 50% wait-time reduction target through fresh installations and service contracts. These programs favor vendors offering low-maintenance magnets and long-term uptime guarantees. Framework tenders covering training and service escalate near-term order pipelines and create predictable revenue across the forecast period for the MRI systems market.

Technological Advancement of MRI Systems

Quantum diamond sensors demonstrated spatial resolution down to ten millionths of a meter, opening cellular-level imaging for pharmaceutical research ^{[2]Dominik Bucher, “New Quantum Sensor Elevates Magnetic Resonance Imaging to the Microscopic Level,” Wiley Analytical Science, analyticalscience.wiley.com} . At the same time, deep-learning reconstruction slashes scan durations from 45 minutes to five without losing diagnostic value. Vendors package these algorithms inside workflow dashboards that auto-route images to subspecialty radiologists, expanding throughput and boosting the economic case for premium models in the MRI systems market.

Adoption of Ultra-Low-Field Portable MRI

FDA-cleared bedside scanners eliminate magnetic shielding, three-phase power, and helium, lowering installed cost by nearly 70% versus fixed rooms. Clinical studies confirm equivalence for specific neuro exams, strengthening confidence among stroke neurologists and ICU teams. Early adopters cite faster throughput and new revenue streams from rural outreach programs, supporting accelerated penetration of portable devices.

Expansion of Privately Funded Imaging Clinics

Private equity–backed chains keep acquiring community centers and layering AI triage software that maximizes asset utilization. RadNet’s USD 103 million purchase of iCAD aligned mammography AI with its multi-state MRI network, enabling same-day scans and rapid reads for self-pay consumers. Growth of these outpatient networks lifts aggregate system demand and reshapes referral patterns within the MRI systems market.

High Capital & Operating Cost of MRI Suites

Full-service installations exceed USD 1 million and require specialized shielding, uninterruptible power, and trained staff. Scanner density in low-income nations remained below 2 units per million population in 2024, underscoring affordability gaps. Leasing and shared-service models partially offset barriers, but life-cycle costs still deter small hospitals and dampen adoption within the MRI systems market.

Helium Supply Constraints & Price Volatility

Periodic shortages pushed helium prices up more than 50% between 2017 and 2025, creating unplanned downtime for facilities that lack recapture systems. Vendors now prioritize cryogen-light or helium-free magnets; however, premium list prices can delay procurement in budget-sensitive regions. Until supply stabilizes, uncertainty restrains capital allocation for new scanners and upgrades.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Architecture: Closed Systems Reign While Portables Surge

Closed platforms delivered 70.74% revenue in 2025 because surgeons and oncologists rely on their high-signal-to-noise images for complex cases. Facilities appreciate the wide coil ecosystem and mature service networks that keep downtime minimal. Yet the portable wave is undeniable: ultra-low-field units post a 6.78% CAGR as emergency departments, trauma centers, and rural hospitals embrace bedside exams that circumvent transport and queuing delays. Vendors consult architects on shielding-lite rooms that streamline upgrades, helping maintain closed-system dominance in the MRI systems market. 

The portable niche unlocks entirely new points of care. Hyperfine’s rolling cart design fits into tight spaces, operates on standard power, and never vents helium. Outcome studies document faster stroke decision-making, which feeds into favorable reimbursement and grants. As clinical evidence expands to musculoskeletal and pediatric use, the segment’s contribution to MRI systems market size will accelerate, though it is unlikely to overtake closed installations in the near term.

By Field Strength: Mid-Range Stability Meets Ultra-High Ambition

At 44.76% share, 1.5 T remains the workhorse because protocols, implants, and radiologist training center on this field. Hospital PACS and contrast media are optimized for its signal profile, preserving a stable installed base across regions. Meanwhile, 7 T delivers the highest growth at 7.12% CAGR, as FDA clearance for clinical neuro scans moves the magnet from research labs into tertiary centers. Price tags hover at USD 10 million, but grant funding and philanthropic gifts help absorb the premium. 

3 T models address applications where higher resolution materially alters care pathways, notably epilepsy surgery planning and cardiac tissue characterization. Vendors that supply both mid- and ultra-high-field lines can upsell within their service contracts, ensuring annuity streams even as MRI systems market share remains weighted toward 1.5 T.

By Application: Neurology Leads; Oncology Climbs Fast

Neurology’s 29.05% slice stems from MRI’s unmatched ability to visualize gray-matter architecture, white-matter tracts, and perfusion patterns without ionizing radiation. Functional and diffusion sequences aid diagnosis of stroke, multiple sclerosis, and traumatic injury, sustaining routine use. Oncology, however, clocks a 7.68% CAGR as metabolic and quantitative imaging spread from academic trials to mainstream practice. Hyperpolarized agents now monitor tumor response days after therapy begins, allowing faster protocol adjustments. 

Musculoskeletal exams gain momentum from sports injury surveillance, whereas cardiology scans benefit from newer compressed-sensing techniques that eliminate breath holds. Each subfield pushes vendors to refine coils, software, and table ergonomics, enlarging the collective MRI systems market size.

By End User: Hospitals Dominate but Outpatient Centers Accelerate

Hospitals still capture 61.72% spending because they manage trauma pathways, intensive care, and surgical staging that require immediate on-site imaging. Their budgets also absorb the capital and facility modifications necessary for high-field magnets. The MRI systems market nevertheless tilts toward outpatient chains, which post 7.02% CAGR by delivering same-day slots and transparent self-pay prices. 

Investors consolidate stand-alone sites into regional brands equipped with standardized scanners and AI decision support. Shorter report turnarounds and patient-friendly scheduling draw referring physicians away from congested hospitals. Mobile fleets further extend reach to employer campuses and assisted-living facilities, broadening the end-user base.

Geography Analysis

Provincial health plans are pushing Canada’s MRI market forward by tying new funding to shorter patient queues. Ontario, for instance, set aside USD 70 million to add scanners, while British Columbia is expanding sites and staff in a bid to halve MRI wait-times by 2030. Because helium supplies are unpredictable, many tenders now specify “helium-free” magnets, a requirement that gives Siemens Magnetom Flow and GE Freelium an edge in competitive bids.

Canada’s publicly funded system creates steady replacement cycles, yet tight budgets mean vendors must prove lower lifetime costs, not just a low sticker price. Regional needs also differ: Ontario and Quebec host the highest scanner counts, whereas western provinces often rely on mobile or shared units to serve patients scattered across large rural areas.

Health Canada’s device rules mirror many FDA standards, so companies with U.S. clearances can enter quickly, though post-market reporting requirements remain uniquely Canadian. Hospitals looking to meet strict wait-time targets are choosing high-throughput models with built-in AI that speeds exams without adding staff. British Columbia, for example, is placing scanners where demand is highest and extending operating hours, favoring vendors that bundle strong service contracts and remote monitoring to keep machines running around the clock.

Regulatory Landscape

In Canada, MRI devices and related software are regulated by Health Canada under the Food and Drugs Act and Medical Devices Regulations (SOR/98-282). Licences are required for Class II, III, and IV devices prior to import or sale, and licence applications rely on a quality management system certification to CAN/CSA-ISO 13485 for higher-risk devices.

Regulatory changes that affect safety claims or scan conditions trigger pre-market review. Manufacturers and importers must report medical device shortages and discontinuations within 30 days of becoming aware. Inspections and establishment licensing are handled by the Regulatory Operations and Enforcement Branch of Health Canada.

Value Chain Analysis

The Canada medical device trade is closely linked to the United States. In 2024, the U.S. accounted for 73 percent of exports and 42 percent of imports, underscoring how much the sector depends on cross-border component sourcing.

The supply base draws on global chains for critical sub-components such as microprocessors, while domestic manufacturing supports items like PPE and surgical instruments. Group purchasing organizations (GPOs) are used by health agencies to consolidate bargaining power and negotiate prices for diagnostic equipment and technology, and HS code 90 category imports accounted for about 53.6 percent of sector imports in 2023.

Market Opportunities and Future Outlook

Clinical integration of machine learning enabled medical devices (MLMD) with predetermined change control plans (PCCP) is emerging as a workable approach to manage model drift risk. In Canada, R&D is also focused on integrating AI, biotechnology, and advanced manufacturing to meet aging population-driven diagnostic needs.

Digital platform implementations can streamline supply chain planning, improve delivery models, and reduce volume requirements for medical devices. In parallel, at-home manufacturing capacity expansion for certain high-demand components complements global sourcing for complex sub-components like microprocessors. Health Canada clearances for ML-enabled features, including the Subtle Medical SubtleHD workflow, provide concrete proof points for regulatory-validated AI adoption.